期刊文献+

小干扰RNA介导的蛋白激酶Cε基因沉默对肾透明细胞癌769P细胞增殖及迁移侵袭的影响 被引量:1

Effects of small interfering RNA against protein kinase CE gene on proliferation, migration and in- vasion of human renal clear cell carcinoma cell line 769P
原文传递
导出
摘要 目的观察下调蛋白激酶Cε(PKCε)基因对。肾透明细胞癌细胞株769P细胞的生长、侵袭及迁移能力的影响。方法用脂质体将PKCε小干扰RNA(siRNA)转染至769P细胞中,逆转录-聚合酶链反应(RT-PCR)及Westernblot分析PKCε基因及蛋白的表达;噻唑蓝(MTT)及单细胞克隆试验测定细胞的生长;划痕及侵袭试验检测细胞的侵袭和迁移能力。结果通过siRNA下调769P细胞中PKCε的表达后,细胞的增殖能力下降明显(P〈0.05);同时,细胞的侵袭和迁移能力较正常细胞降低,差异有统计学意义(P〈0.05)。结论PKCε可影响人肾透明细胞癌细胞株769P细胞的生长及细胞侵袭、迁移能力。 Objective To evaluate the effects of small interfering RNA (siRNA) against protein kinase C~ (PKCa) gene on the proliferation, migration and invasion of human clear cell RCC cell line 769P cells. Methods FKCε-siRNA was transfected into the 769P cells. The mRNA and protein expres- sion of PKCε was detected by using reverse transcription polymerase chain reaction (RT-PCR) and West- ern blotting, respectively. The proliferation of 769P cells was measured by methyl thiazol tetrazolium (MTT) assay and colony formation assay. Cell migration and invasion was assessed by using wound-healing assay and CHEMICON cell invasion assay, respectively. Results PKCε-siRNA efficiently down-regulated the PKCε expression, which resulted in inhibition of the proliferation, migration, and invasion of clear cell RCC cell line 769P. Conclusion PKCais may be related with proliferation, migration and invasion of 769P cells, and may be a potential therapeutic target for clear cell RCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第11期2243-2245,共3页 Chinese Journal of Experimental Surgery
基金 广东省科技计划资助项目(20088080701021)
关键词 蛋白激酶CΕ 肾透明细胞癌 小干扰RNA Protein kinase Cε Renal clear cell carcinoma Small interfering RNA
  • 相关文献

参考文献16

  • 1Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer,2007,7:281-294.
  • 2Gutcher I, Webb PR, Ande~on NG. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci,2003,60: 1061- 1070.
  • 3Gorin MA, Pan Q. Protein kinase Ca : an oncogene and emerging tumor biomarker. Mol Cancer,2009,8:9.
  • 4Basu A, Sivaprasad U. Protein kinase Cε makes the lite and death de- cision. Cell Signal ,2007,19 : 1633-1642.
  • 5Akita Y. Protein kinase Cepsilon : multiple roles in the function of and signaling mediated by, the cytoskeleton. FEBS J, 2008,275 : 3995- 4004.
  • 6Akita Y. Protein kinase Ca ( PKCa ) : its unique structure and func- tion. J Biochem ,2002,132 : 847-852.
  • 7Totofi E, Ignatowicz E, Skrzeczkowska K, et a]. Protein kinase Cz as a cancer marker and target for anticancer therapy. Phannacol Rep, 2011,63:19-29.
  • 8王奎军,徐斌,孙喜国,周芳堃,李存杰.小干扰RNA对肾癌786-O细胞Survivin表达及其增殖的抑制作用[J].中华实验外科杂志,2010,27(6):795-797. 被引量:4
  • 9Klatte T, Pantuck A J, Kleid MD, et al. Understanding the natural biol- ogy of kidney cancer: implications for targeted cancer therapy. Rev Uro1,2007 ,9 :47-56.
  • 10Finley I)S, Pantuck A J, Belldegrun AS. Tumor biology and prognostic factors in renal cell carcinoma. Oncologist, 2011,16:4 - 13.

二级参考文献5

共引文献3

同被引文献18

  • 1Nigg EA. Mitotic kinases as regulators of cell division and its check- points[ J]. Nat Rev Mol Cell Biol,2001,2( 1 ) :21-32.
  • 2Clover DM, Leibowitz MH, McLean DA, et al. Mutations in aurora prevent centrosome seperation leading to the formation of monopolar spindles [J]. Cell, 1995,81 ( 1 ) :95-105.
  • 3Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/ BTAK induces centrosome amplification, aneuploidy and transformation[J]. Nat Genet, 1998,20(2) : 189-193.
  • 4Pahngren JS, Karavadia SS, Wakefield MR. Unusual and underappre- ciated : small cell carcinoma of the prostate [ J ]. Semin Oncol, 2007, 34( 1 ) :22-29.
  • 5Beltran H, Rickman DS, Park K, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets [ J ]. Cancer Discov ,2011,1 (6) :487-495.
  • 6Otto T,Horu S,Brockmann M,et al. Stabilization of N-Myc is a criti- cal function of AURKA in human neumblastoma [ J ]. Cancer Cell, 2009,15(1 ) :67-78.
  • 7Marls JM. Unholy matrimony:Aurora A and N-Myc as malignant part- ners in neuroblastoma[ J]. Cancer Ce11,2009,15 (1) :5-6.
  • 8Iqbal J, Weisenburger DD, Chowdhury A, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadeha T-cell lymphoma and is highly sensi- tive to a novel aurora kinase A inhibitor in vitro[ J]. Leukemia,2011, 25 (2) :348-358.
  • 9Li L,Yang G,Ren C,et al. Glioma pathogenesis-related protein 1 in- duces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2[ J]. Mol Oneol,2013,7 (3) :484-496.
  • 10Iotas E, Lord CJ, Turner N, et al. Utilizing RNA interference to en- hance cancer drug discovery [J]. Nat Rev Drug Discov,2007,6 (7) : 556-568.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部